$9.01
+0.410 (+4.77%)
At Close: Aug 04, 2026
Are These Marijuana Stocks Worth Buying Or Selling?
07:00am, Wednesday, 13'th Sep 2023
Marijuana stocks have seen several days of better trading this past week. There were a few days when the cannabis sector was showing better momentum. This led to a recovery for certain marijuana stock
New York State opens up cannabis license process
02:46pm, Tuesday, 12'th Sep 2023
The New York State Cannabis Control Board on Tuesday voted to open up the application process starting next month for businesses seeking to sell, grow, process and distribute marijuana for adult use.
Why Marijuana Stocks Triumphed on Monday
06:47pm, Monday, 11'th Sep 2023
The House of Representatives is set to meet to discuss several pot-related measures this week. The march toward full U.S. legalization continues to gather pace.
The 3 Best Cannabis Stocks to Buy Now: September 2023
04:11pm, Sunday, 10'th Sep 2023
With cannabis usage continuing to rise, now could be an opportune time to invest in marijuana stocks. Over 52 million Americans currently use cannabis, and legalization seems inevitable as more states
These Marijuana Stocks Could Be Top Gainers In September
10:54am, Sunday, 10'th Sep 2023
Marijuana stocks could soon see better trading in the weeks to come. For some time now most marijuana stocks have traded with a level of volatility. This can make it both easier and tougher to trade a
Why Canopy Growth, Aurora Cannabis, and Curaleaf Stocks All Popped Today
03:45pm, Friday, 08'th Sep 2023
Momentum for passage of marijuana reform legislation keeps growing, and senators are confident the SAFE Banking Act will pass. A new study touts the benefits of medical marijuana for pain amelioration
3 Medical Cannabis Stocks Poised for Global Growth
09:06am, Friday, 08'th Sep 2023
The global buzz around medical cannabis stocks just got a whole lot louder. The corridors of the U.S. health sector are abuzz with the federal Health and Human Services Department urging the governmen
Cannabis stocks gain as banking bill finds traction in Senate, but House OK looks challenging
03:14pm, Thursday, 07'th Sep 2023
Cannabis stocks advanced Thursday, helped by news that a key Senate committee could soon vote to advance a widely followed bill that aims to make it easier for the financial industry to work with cann
Marijuana rescheduling would be ‘life-changing event' for cannabis companies, CEOs say
01:20pm, Wednesday, 06'th Sep 2023
The rescheduling of marijuana from a Schedule I to Schedule III drug in the United States would be transformative for the cannabis sector, CEOs of leading cannabis companies believe. Last week, the
Medical-cannabis companies blast New York for ‘clear course for failure' in state pot-business rollout
11:40am, Wednesday, 06'th Sep 2023
New York state's largest medical-cannabis companies, which have been barred from wading into the adult-use market for more than two years, are saying they've waited long enough for licenses from the s
Will This New Development Mean A Big Rally In Cannabis Stocks?
07:27am, Wednesday, 06'th Sep 2023
Curaleaf Holdings Inc. OTCMKTS: CURLF, Innovative Industrial Properties Inc. NYSE: IIPR and Tilray Inc. NASDAQ: TLRY were among cannabis stocks jumping higher after the Department of Health and Huma
Cannabis stock rally continues on marijuana rescheduling hopes
12:42pm, Tuesday, 05'th Sep 2023
Cannabis stocks continued to move higher following the Labor Day long weekend after the U.S. Department of Health and Human Services (HHS) last week recommended reclassifying marijuana as a lower-risk
2 Marijuana Stocks To Watch In September 2023
01:43pm, Monday, 04'th Sep 2023
Marijuana stocks to watch this month.
3 Marijuana Stocks To Watch Today 2023
12:58pm, Monday, 04'th Sep 2023
Those looking for the best marijuana stocks to buy could be in luck. The level of volatile trading occurring in the market has led to a consistent decline in trading. Now most think when there is a dr
Marijuana's reclassification is 'long overdue' by the DEA: Curaleaf CEO
10:00am, Monday, 04'th Sep 2023
Following urgings by the U.S. Department of Health & Human Services, DEA officials could reclassify marijuana's drug status to that of a Schedule III substance. Curaleaf (CURLF) CEO Matt Darin joins Y
Sign In
Buy CURLF